Before arguing about classification, write the product fact sheet

The job is to turn that uncertainty into a product fact sheet the team can inspect, revise, and carry into the next decision.

The first review artifact should show:

Write the product fact sheet first so intended use, target user, use environment, current alternative, comparator, and open review questions become visible.

A useful product fact sheet turns the debate into an explicit operating brief. It names what is being prepared, which source-backed facts or public signals support the current view, what changes for the founder team next, and which statements remain assumptions or review-only language. That detail matters because an early commercial team usually loses momentum when it jumps from abstract positioning language to an outreach sequence without first deciding which person feels the cost of doing nothing, what event forces that person to pay attention, and what exact sentence should be tested before any broader launch story is written.

The useful commercial question is not whether every account will react the same way. The useful question is what a real person inside the account must decide next, what evidence they need, and what message would make that next step easier to review without overstating product claims or market certainty. A practical draft should therefore connect the buying scene to workflow burden, internal coordination, training cost, timing pressure, and the specific proof the buyer or internal teammate would ask for before agreeing that the product deserves another meeting.

The core artifact for this scene is a product fact sheet. It should make the first commercial move visible instead of leaving the team with a broad market label.

The product fact sheet should be concrete enough for the team to inspect: who owns the pain, what changed today, what internal proof is still missing, and what exact follow-up the next call should produce.

For this scene, the team should use the product fact sheet to separate source-backed facts, working assumptions, open questions, and the next review step.

The draft should answer five reviewable questions:

The artifact should make the current situation visible enough that a qualified reviewer can challenge the exact assumption, wording, signal, or missing source that matters next.

That keeps the work tied to the real founder problem instead of broad marketing language, scattered notes, or a generic story that no one can inspect later.

This also connects the immediate scene to the wider market-entry system: the same product fact sheet can sharpen later investor, buyer, consultant, training, or support conversations once the first version is reviewed.

TrueMedDevice can prepare the draft artifact, source-linked notes, and open-question framing for qualified internal and external review. The manufacturer and its qualified reviewers still decide product, clinical, regulatory, legal, quality, reimbursement, and commercial conclusions.

We built a Market-Ready Sales & Support Pack for medical-device teams preparing to sell, explain, train, and support customers around United States market entry or early commercialization. I can send the one-page overview if useful.

The internal review handoff should carry forward two practical questions: does the next step stay aligned to a concrete market-entry preparation need rather than a vague services pitch, and are clinical, regulatory, legal, quality, and reimbursement boundaries explicit enough? The boundary notes should stay with the draft so a commercial message does not drift into unsupported regulatory or legal conclusions. The article should help the team ask better questions, not prematurely answer them, and should leave behind a usable record of what was assumed, what was observed, what still needs verification, and who owns the next refinement.

The article should also make the current alternative visible in plain language. Buyers do not switch because a company says its product is innovative. They switch because the current process is slow, fragmented, manual, risky, expensive, hard to train, or politically difficult to defend. A review-ready scene therefore compares the proposed path with the status quo and names the change in behavior the team is actually asking the account to make.

Finally, the scene should end with a concrete next action. That next action could be a founder call outline, a distributor briefing page, a committee-prep memo, or a customer-proof request list. What matters is that the artifact is short enough to use before the next meeting, specific enough to survive internal scrutiny, and narrow enough that the team can tell whether the buyer hypothesis improved after one more test.

A product fact sheet should answer: intended use, target user, use environment, current alternative, comparator assumptions, claim boundaries, and the question that needs qualified review.

Use one review-ready artifact to show what changed, what is source-backed, what stays open, and what qualified review still needs to decide.

If your team is still debating product definition, we can prepare a Product Fact Sheet that turns the debate into reviewable facts and open questions.